Bio Adipic Acid Market Size, Industry Analysis Report, Regional Analysis, Downstream Application Development Potential, Price Trend, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI336
Bio adipic acid market size is likely to see significant growth as planned capacities come online over the next few years. Adipic acid market size was estimated at over 2.7 million tons in 2015 and is likely to exceed 4 million tons by 2023, growing at a CAGR of more than 4.5%. Adipic acid (ADA) market revenue was over USD 4.5 billion in 2015 and is likely to reach USD 7.4 billion by 2023.
Nylon 6,6 was the largest application and accounted for more than 80% of the total volume in 2015. Polyurethane (PU) application is likely to be the fastest growing at gains of over 5.2% from 2016 to 2023.
Asia Pacific adipic acid market size was estimated over 940 kilo tons in 2015 and is likely to witness highest gains of over 5% from 2016 to 2023. North America market is likely to be worth more than USD 2 billion by 2023 with expected gains of over 6%.
The bio adipic acid market is still at the infancy stage as few companies have focused on research to commercialize production. Companies such as Verdezyne, DSM, BioAmeber, Ameris, Aemethis, Genomatica and Rennovia have successfully designed production technology to develop 100% bio ADA and would be commercializing the product over the coming years. Adipic acid market price trend is expected to remain stable between USD 1.6 to USD 1.9 per kilo.
Increasing nylon 6.6 demand for durable application such as automobiles, textile, carpets, tire-cod and technical fibers is likely to drive bio adipic acid market. Industry participants are vying to manufacture 100% bio based nylon for industrial applications owing to stringent government policies over environmental concerns. Global nylon 6,6 market was estimated at over 1.3 million tons in 2013 and is likely to grow at a CAGR of over 4% from 2016 to 2023.
In 2013, Rennovia announced successful completion of 100% bio based nylon 6,6. It is based on combination of Rennovia’s RENNLON bio based adipic acid and hexamethylenediamine (HMD). Rennovia is able to manufacture both the products through its patented chemical catalytic process technology. Rennovia bio adipic acid production is through anaerobic oxidation of glucose to obtain glucaric acid which further goes hydrooxygenation.
Rennovia products are estimated to be cost competitive in comparison to petrochemical based products. The company is targeting to commercialize bio-based adipic acid market with an initial capacity of 135 kilo tons per annum by the end of 2018.
Verdezyne is invested in research to develop bio ADA through fermentation technique using yeast microorganism which can utilize plant based oil, alkanes or sugar as feedstock. In 2013, the company announced collaboration with Malaysia’s biotechnology investment group, Biotechcorp (Malaysian Biotechnology Corporation). This would help the company to access Malaysia as the prime location to set up biotechnological production facility and is likely to procure local feedstock such as palm fatty acids and palm kernel oil distillates for manufacturing the end product.
It is produced traditionally from petrochemical based feedstock such as cyclohexane, benzene and phenol. Cyclohexane based process accounts for over 90% of the production volume. Tight supply and volatile prices of cyclohexane is likely to affect industry profitability. Companies are focusing on green alternative routes to mitigate the risks as this could prove to be more beneficial in terms of cost and also would be entitled for government incentives in the form of subsidies & loan guarantees.
Technologies developed from Rennovia and Verdezyne can prove to be cost effective as both the process requires glucose as feedstock, available at competitive market rates in comparison to cyclohexane. Hoverever, there are significant challenges to be met in terms of high yield and catalyst productivity.
Growing preference of bio PU market in applications such as construction, electronics and automotive is likely to drive bio adipic acid market growth. It also finds applications in food and medical industries. It is used as flavor and gelling aid for food preparations.
Stringent norms by FDA over nitrogen dioxide emission from conventional adipic acid are likely t0 favor bio based adipic acid market growth. Its polymeric coatings are used in hydrophilic drugs & other controlled drug release formulations for medical applications.
With established companies such as Invista, BASF, Honeywell and PetroChina in the conventional space and a number of innovative start-ups developing sustainable technology, adipic acid market share may fragment over the next five years.
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.